JPRN-jRCT2080221499未知2 期
Prevention of Recurrent Gastric or Duodenal Ulcers caused by Low-dose Aspirin with Rabeprazole (E3810) Treatment. -A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial-(Planetarium study)
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Require long-term administration of low-dose aspirin (81 mg/day or 100 mg/day).
- •Confirmed to have a history of gastric or duodenal ulcer.
排除标准
- •Confirmed to have acute gastroduodenal mucosal lesions, gastric or duodenal ulcer, or upper gastrointestinal (esophagus, stomach, duodenum) bleeding.
- •Confirmed to have reflux esophagitis or long segment Barrett's esophagus.
研究者
相似试验
已完成
2 期
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)Gastric or Duodenal Ulcers Caused by Low-dose AspirinNCT01397448Eisai Co., Ltd.472
未知
2 期
ong-term administration study of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriJPRN-jRCT2080221500Eisai Co., Ltd.300
招募中
4 期
Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal UlcerActive Peptic Ulcer Disease/GI BleedingNCT03675672Chinese University of Hong Kong154
进行中（未招募）
1 期
Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidineEUCTR2005-004849-33-GBHS Greater Glasgow700
招募中
不适用
Prevention of gastrointestinal complications by infusion pump in patients receiving enteral nutritioInpatients receiving enteral nutrition via nasogastric tube, gastric fistula, or intestinal fistulaJPRN-UMIN000005609Division of Clinical pharmacokinetics, Faculty of Pharmacy, Keio University200